Preclinical CRO Accelerating Drug Development
Accelerate your preclinical research
We are an advanced preclinical CRO that provides comprehensive solutions across drug and device development phases. Our services include contract research and development, bioanalysis, analytical testing, pharmacodynamic modeling, preclinical safety testing, and more.
Top contract research organization
Accelerate your preclinical research
We are an advanced preclinincal CRO that provides advanced comprehensive solutions across drug and device development phases including bioanalysis, contract research and development, clinical CRO, advanced preclinical services, analytical testing, GLP lab, discovery and research, pharmacodynamic modeling, and preclininal safety testing.
Top contract research organization
Accelerate your preclinical research
We are an advanced preclinical CRO that provides comprehensive solutions across drug and device development phases. Our services include contract research and development, bioanalysis, analytical testing, pharmacodynamic modeling, preclinical safety testing, and more.
“We needed a local CRO that is flexible and fast-paced to support our AAV gene therapy research and preclinical programs. Luckily, we found Noble who exceeded our expectations. Our teams work seamlessly as if they are an extension of our lab and provided necessary resources to advance our research in the most cost-effective way.”
– VP, Target Discovery & Early Portfolio
“Noble has been instrumental in enabling the accelerated testing of Jaguar’s preclinical gene therapy program. We are impressed by Noble’s experience and unparalleled support. As a leader in drug, device, and vaccine development, Noble appreciates the significance of Jaguar’s mission to accelerate breakthroughs in gene therapy for patients suffering from severe genetic diseases.”
“Noble has been a strong partner for us, helping to accelerate testing of our synthetic biologics. Our Amicidins are new and innovative, requiring special attention to local application and performance in models. Noble has been flexible and agile in meeting our needs with high-quality work. We are pleased with the part Noble has played in advancing our programs, as we look to prevent and treat life-threatening infections in surgery and trauma.”
– Director, Preclinical Development
– CEO, Britecyte, Inc.
– Co-Founder, DEKA BioSciences
Moving in unison with you toward your goals with preclinical testing and bioanalytical expertise and services that deliver your drug to market faster. Uncover new opportunities that will impact and transform lives with Noble Life Sciences.
Advance your innovation. Reduce risk. Achieve compliance.
Preclinical, IND Enabling, GLP Toxicology
Our preclinical services include contract research and development, safety testing, in vitro and in vivo testing, animal and drug testing, formulation development, translational research, laboratory, and pathway services.
Advance your innovation. Reduce risk. Achieve compliance.
Preclinical, IND Enabling, GLP Toxicology
Our preclinical services including contract research, research services, pathway services, safety testing, development services, in vitro and in vivo testing, animal testing, drug testing, formulation development services, R&D, lab services and translational services.
Advance your innovation. Reduce risk. Achieve compliance.
Preclinical, IND Enabling, GLP Toxicology
Our preclinical services include contract research and development, safety testing, in vitro and in vivo testing, animal and drug testing, formulation development, translational research, laboratory, and pathway services.
Therapeutic Areas
Get your drug to market faster and uncover new opportunities to impact people’s lives with our research expertise.
Oncology
Oncology
As an oncology contract research organization, our preclinical oncology and immuno-oncology services include cancer preclinical animal model testing, in vivo cancer models, OncoDiversity Cell Line Panel, and Pharmacodynamic Models.
Infectious Diseases
Infectious Diseases
Our infectious disease services include SARS-CoV-2 research solutions, antiviral testing labs, and vaccine research for influenza and RSV drug development. We also offer antiviral, antibacterial drug and vaccine discovery and development for a multitude of viral and bacterial pathogens that lead to sepsis.
Diabetes
Diabetes
World-class scientists. Groundbreaking technology.
Cell & Gene Therapy
From the early stages of cell and gene therapy development, our goal is to make your transition from discovery to commercialization as seamless as possible. We are dedicated to delivering the highest quality cell and gene development services.
Advance your innovation. Reduce risk. Achieve compliance.
Cell & Gene Therapy
Need to change content. Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Advance your innovation. Reduce risk. Achieve compliance.
Cell & Gene Therapy
From the early stages of cell and gene therapy development, our goal is to make your transition from discovery to commercialization as seamless as possible. We are dedicated to delivering the highest quality cell and gene development services.
Devices
Get your device to market faster and uncover new opportunities to impact people’s lives with our research expertise.
Facilities & Compliance
Learn about our state-of-the-art facility with a commitment to compliance.
Facilities
Facilities
Compliance
Compliance
Resources & White Papers
PASSIONATE ABOUT COLLABORATING FOR A CURE
Mouse Peritonitis/Sepsis Model of MRSA Infection
Introduction Noble Life Sciences, in collaboration with ImQuest Biosciences, has optimized the peritonitis/sepsis mouse model to screen for new antibacterial agents against...
Animal Models for the development of vaccines and therapeutics for influenza infections
The mouse and ferret animal models are the most widely used models for influenza studies. Each has its advantages. The...
Immunophenotyping of Tumor-Infiltrating Immune Cells in Mouse Syngeneic Tumor Models Using Multi-Color Flow Cytometry Assays
The in vivo animal tumor models possessing fully functional immunity are essential for preclinical...
Biodistribution Studies for Cell and Gene Therapy Products
Figure 1. Overview of the biodistribution study of cell/gene therapy (CGT) product. The CGT product is injected into mice; tissue samples are harvested and DNA is isolated from...